Skip to main content
Home
FULL MENU Close Menu
Home
Home

Jennifer Smith

Jennifer Smith is the editor of Oncology Practice, part of MDedge Hematology/Oncology. She was previously the editor of Hematology Times, an editor at Principal Investigators Association, and a reporter at The Oneida Daily Dispatch. She has a BS in journalism.

News

Combo produces disappointing PFS, promising OS in metastatic colorectal cancer

Author:
Jennifer Smith
Publish date: November 13, 2019

NATIONAL HARBOR, MD. – Combination avelumab and cetuximab plus oxaliplatin, leucovorin, and 5-fluorouracil failed to meet the primary endpoint for...

  • Read More

News

CAR T cells in a bag

Armored CAR T cells elicit responses in NHL patients

Author:
Jennifer Smith
Publish date: November 12, 2019

NATIONAL HARBOR, MD. – ICTCAR014, a dominant negative PD-1 armored CAR T-cell therapy, produced responses in 12 of 13 non-Hodgkin lymphoma...

  • Read More

News

Combo shows promise for checkpoint inhibitor-refractory urothelial carcinoma

Author:
Jennifer Smith
Publish date: November 12, 2019

NATIONAL HARBOR, MD – Combination sitravatinib and nivolumab produced responses in patients with checkpoint...

  • Read More

News

TLR9 agonist may overcome resistance to anti–PD-1 therapy in melanoma

Author:
Jennifer Smith
Publish date: November 12, 2019

NATIONAL HARBOR, MD. – CMP-001 plus pembrolizumab produced durable responses in patients who had progressed on prior...

  • Read More

News

Smokers with PE have higher rate of hospital readmission

Author:
Jennifer Smith
Publish date: November 11, 2019

NEW ORLEANS – The rate of readmission within 30 days was significantly higher among PE patients with tobacco...

  • Read More

News

Molecule exhibits activity in heavily pretreated, HER2-positive solid tumors

Author:
Jennifer Smith
Publish date: November 11, 2019

NATIONAL HARBOR, MD – In a phase 1 trial of 18 evaluable patients, PRS-343, a 4-1BB/HER2 bispecific molecule,...

  • Read More

News

Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression

Author:
Jennifer Smith
Publish date: November 10, 2019

Atezolizumab provided a 7-month benefit in median overall survival for patients with stage IV non–small cell lung cancer and high PD-L1 expression...

  • Read More

News

Dupilumab effective in early- and late-onset asthma

Author:
Jennifer Smith
Publish date: November 7, 2019

NEW ORLEANS – Dupilumab may be more effective in reducing severe asthma exacerbations in patients with late-onset asthma.

  • Read More

News

Robotic bronchoscopy beat standard techniques for targeting lung nodules

Author:
Jennifer Smith
Publish date: November 5, 2019

NEW ORLEANS – Robotic bronchoscopy targeted lung nodules more effectively than did electromagnetic navigation or an ultrathin bronchoscope with...

  • Read More

News

Fluoroscopic system can improve targeting of lung lesions

Author:
Jennifer Smith
Publish date: November 4, 2019

The system increased the percentage of cases in which the target overlapped with the lesion.

  • Read More

Article

Blood banking experts nab leadership positions at AABB

Author:
Jennifer Smith
Publish date: November 4, 2019

AABB announces a new president, president-elect, vice president, and secretary.

  • Read More

News

Macitentan produces similar results in PAH-SSc and IPAH/HPAH

Author:
Jennifer Smith
Publish date: October 30, 2019

NEW ORLEANS – Rates of discontinuation, adverse events, and survival were similar in patients with PAH-SSc and those with IPAH or HPAH.

  • Read More

News

Omalizumab results for asthma varied with fixed airflow obstruction, reversibility

Author:
Jennifer Smith
Publish date: October 28, 2019

Omalizumab only improved lung function significantly in FAO-negative patients with high reversibility.

  • Read More

News

Macitentan, tadalafil combo found effective for newly diagnosed PAH

Author:
Jennifer Smith
Publish date: October 22, 2019

Macitentan and tadalafil demonstrated efficacy in a phase 4 trial.

  • Read More

Article

Physician-researcher who promoted industry collaboration dies unexpectedly

Author:
Jennifer Smith
Publish date: October 22, 2019

Dr. Thomas Peter Stossel died on Sept. 29 at the age of 78. He was best known for his discovery of the cellular proteins filamin and gelsolin.

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close